These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

614 related items for PubMed ID: 16710790

  • 1. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study.
    Albert US, Koller M, Kopp I, Lorenz W, Schulz KD, Wagner U.
    Breast Cancer Res Treat; 2006 Dec; 100(3):285-92. PubMed ID: 16710790
    [Abstract] [Full Text] [Related]

  • 2. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.
    Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, Kissin M, Mansel RE.
    Breast Cancer Res Treat; 2006 Feb; 95(3):279-93. PubMed ID: 16163445
    [Abstract] [Full Text] [Related]

  • 3. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.
    Rietman JS, Geertzen JH, Hoekstra HJ, Baas P, Dolsma WV, de Vries J, Groothoff JW, Eisma WH, Dijkstra PU.
    Eur J Surg Oncol; 2006 Mar; 32(2):148-52. PubMed ID: 16387467
    [Abstract] [Full Text] [Related]

  • 4. Changes in arm morbidities and health-related quality of life after breast cancer surgery - a five-year follow-up study.
    Sagen A, Kåresen R, Sandvik L, Risberg MA.
    Acta Oncol; 2009 Mar; 48(8):1111-8. PubMed ID: 19863218
    [Abstract] [Full Text] [Related]

  • 5. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
    Mak SS, Yeo W, Lee YM, Mo KF, Tse KY, Tse SM, Ho FP, Kwan WH.
    Nurs Res; 2008 Mar; 57(6):416-25. PubMed ID: 19018216
    [Abstract] [Full Text] [Related]

  • 6. Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer.
    Barranger E, Dubernard G, Fleurence J, Antoine M, Darai E, Uzan S.
    J Surg Oncol; 2005 Oct 01; 92(1):17-22. PubMed ID: 16180226
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Arm morbidity after axillary dissection for breast cancer].
    Stahlberg CI, Jørgensen T.
    Ugeskr Laeger; 2001 Jun 11; 163(24):3356-9. PubMed ID: 11434124
    [Abstract] [Full Text] [Related]

  • 12. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.
    Petrik DW, McCready DR, Sawka CA, Goel V.
    J Surg Oncol; 2003 Feb 11; 82(2):84-90. PubMed ID: 12561062
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Implications of a postoperative rehabilitation program on quality of life in women with primary breast cancer treated with sentinel lymph node biopsy or complete axillary lymph node dissection.
    Pinto e Silva MP, Sarian LO, Morais SS, Pace do Amaral MT, Freire de Oliveira MM, Derchain S.
    Ann Surg Oncol; 2008 Dec 11; 15(12):3342-9. PubMed ID: 18931880
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.
    Nesvold IL, Dahl AA, Løkkevik E, Marit Mengshoel A, Fosså SD.
    Acta Oncol; 2008 Dec 11; 47(5):835-42. PubMed ID: 18568481
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Factors influencing arm and axillary symptoms after treatment for node negative breast carcinoma.
    Yap KP, McCready DR, Narod S, Manchul LA, Trudeau M, Fyles A.
    Cancer; 2003 Mar 15; 97(6):1369-75. PubMed ID: 12627499
    [Abstract] [Full Text] [Related]

  • 20. Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial).
    Smith MJ, Gill PG, Wetzig N, Sourjina T, Gebski V, Ung O, Campbell I, Kollias J, Coskinas X, Macphee A, Young L, Simes RJ, Stockler MR, Royal Australasian College of Surgeons SNAC Trial Group.
    Breast Cancer Res Treat; 2009 Sep 15; 117(1):99-109. PubMed ID: 18925434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.